This content is from: Portfolio With the Pullback in IPOs, Shareholders in Private Companies Are Selling — And Prices Are Dropping With the rise of Forge and other platforms, employees, hedge funds, and other investors are getting liquidity even though the window to go public has closed. By Hannah Zhang April 21, 2022
This content is from: Premium Hedge Funds Are Holding Their Breath on This Biopharma IPO Several prominent hedge funds disclosed sizable stakes in PepGen, which went public earlier this month. By Stephen Taub May 23, 2022
This content is from: Premium Anaplan Activists Are Quickly Rewarded A sizable number of hedge funds are poised to benefit from the cloud computing company’s deal with Thoma Bravo. By Stephen Taub March 21, 2022
This content is from: Culture With Too Much Love From Institutional Investors, Companies With High ESG Ratings May be Overvalued. Activists Are Taking Note. Activists and others are looking for companies with low marks on environmental, social, and governance check lists. By Jessica Hamlin April 22, 2022
This content is from: Portfolio Here’s What Companies Can Return When They Don’t Just Focus on Shareholders Companies that make decisions based on the effect on local communities or the labor force may suffer in the short term — but they’re better performers in the long run. By Jessica Hamlin January 18, 2022
This content is from: Corner Office Can Fund Managers’ Fee Cuts Win Back Clients? Active and passive managers brought in one-third of the amount of money in the first quarter of 2022 as they did a year earlier. Blame volatility and competition from alternatives. By Hannah Zhang May 05, 2022
